O togafitiga mo le kanesa o le susu e faalagolago i vala eseese e pei o le tulaga o le kanesa, le ituaiga o kanesa, le tulaga o le soifua mālōlōina o le tagata maʻi, ma mea e fiafia i ai.
O nisi o togafitiga masani e aofia ai:
1. Taotoga: E aofia ai le aveeseina o le tuma ma isi vaega o le tino o loo siʻomia ai.
E eseese ituaiga o taotoga e faia, e aofia ai le aveeseina o le paʻu o le susu, le aveeseina o le susu, ma le aveeseina o sela o le tino.
2. Togafitiga e faaaogā ai le malosiaga o le lā e taia ai sela o le kanesa ma faaitiitia ai le telē o le tuma.
E masani ona faaaogā pe a uma se taotoga e fasiotia ai sela o le kanesa o loo totoe.
3. Togafitiga o le kanesa e ala i vailaau: O lenei togafitiga e aofia ai le faaaogāina o fualaau e fasiotia ai sela o le kanesa.
E mafai ona tui i totonu o le uaua po o le gutu ma e masani ona faaaogā e faaitiitia ai le tuma a o leʻi faia se taotoga, pe fasiotia ai foʻi sela o le kanesa pe a uma le taotoga.
4. Togafitiga o le Hormone: E faaaogā lenei togafitiga mo le kanesa o le susu e maua i le hormone-receptor-positive ma e taofia ai le gaosiga o homone lea e faatupuina ai le tuputupu aʻe o sela o le kanesa.
5. Togafitiga e fuafua lelei: O lenei togafitiga e faaaogā ai fualaau e fuafua lelei ai vaega ninii o loo aafia i le tuputupu aʻe ma le sosolo o sela o le kanesa.
6. Togafitiga o le kanesa: E fesoasoani lea i le faiga e puipuia ai le tino mai i faamaʻi, ina ia iloa ma osofaʻia sela o le kanesa.
7. Suʻesuʻega Faafomaʻi: E ono mafaufau foʻi tagata mamaʻi e auai i suʻesuʻega faafomaʻi ina ia maua ai togafitiga fou ma faataʻitaʻi.
E tāua le talanoaina o togafitiga e sili ona lelei ma le vaega o loo faia togafitiga, auā o le a fuafua le togafitiga e tusa ma manaʻoga ma tulaga o le tagata.
E lē gata i lea, o togafitiga e pei o le puleaina o le tigā, le fesoasoani i faalogona, ma le taʻitaʻiga i meaʻai e mafai ona avea ma vaega o le togafitiga.
Kumar L, Baldi A, Verma S, Utreja P: Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer. Pharm Nanotechnol. 2018, 6 (2): 94-110.
Mehrgou A, Akouchekian M: Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease. J Res Med Sci. 2017, 22 (): 130.
Ng AK, Travis LB: Radiation therapy and breast cancer risk. J Natl Compr Canc Netw. 2009, 7 (10): 1121-8.
Ligresti G, Libra M, Militello L, Clementi S, Donia M, Imbesi R, Malaponte G, Cappellani A, McCubrey JA, Stivala F: Breast cancer: Molecular basis and therapeutic strategies (Review). Mol Med Rep. , 1 (4): 451-8.
Bricou A, Barranger E: Response to the article by Evangelista et al.: Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting. Breast Cancer Res Treat 2014. Breast Cancer Res Treat. 2014, 148 (1): 231-2.
Daniyal A, Santoso I, Gunawan NHP, Barliana MI, Abdulah R: Genetic Influences in Breast Cancer Drug Resistance. Breast Cancer (Dove Med Press). 2021, 13 (): 59-85.
Li X, Bu X: Progress in Vaccine Therapies for Breast Cancer. Adv Exp Med Biol. 2017, 1026 (): 315-330.
['Faamatalaga: faafomaʻi']
['O lenei upega tafaʻilagi ua saunia mo na o le aʻoaʻoina ma le faailoaina atu o faamatalaga, ae e lē o se fautuaga faafomaʻi po o se auaunaga faapolofesa.']
['E lē tatau ona faaaogā faamatalaga o loo maua mai ai e iloa ai po o le ā le maʻi o loo aafia ai, ma e tatau i ē o loo saʻili mo ni fautuaga faafomaʻi, ona talanoa atu i se fomaʻi ua agavaa.']
['Faamolemole ia mātau, o le neural net lea e maua ai tali i fesili, e lē saʻo pe a oo i fuainumera.']
["Ia saʻili i taimi uma le fautuaga a lau fomaʻi poʻo se isi fomaʻi agavaa e tusa ai ma se maʻi. Aua neʻi e le amanaʻia fautuaga faʻapitoa a fomaʻi pe tuai ona saili ona o se mea na e faitauina i luga o lenei upega tafailagi. Afai e te manatu e ono i ai sau faʻalavelave faʻafuaseʻi, valaʻau le 911 pe alu i le potu lata ane faʻafuaseʻi. E leai se fomaʻi-tagata gasegase sootaga e faia e lenei 'upega tafaʻilagi poʻo lona faʻaaogaina. E leai se BioMedLib poʻo ana tagata faigaluega, poʻo se tasi e fesoasoani i lenei' upega tafaʻilagi, faia ni faʻamatalaga, faʻaalia pe faʻaalia, e tusa ai ma faʻamatalaga o loʻo tuʻuina atu iinei poʻo lona faʻaaogaina."]
['Faʻasalaga: puletaofia']
['O le Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (le DMCA) e maua ai le avanoa mo tagata e umia le puletaofia o loʻo talitonu o mea o loʻo aliali mai i luga o le Initaneti e solia ai a latou aia tatau i lalo o le tulafono a le US copyright. ']
['Afai e te talitonu ma le talitonuga lelei e faapea o so o se mataupu po o meafaitino ua maua e fesootai ma lo tatou website po o auaunaga solia lou puletaofia, e mafai ona e (po o lou sooupu) auina atu i tatou se faasilasilaga talosagaina e faapea o le mataupu po o meafaitino e aveesea, po o le avanoa i ai poloka. ']
['E tatau ona auina atu faasilasilaga i se faiga tusitusia e ala i imeli (tagai i le vaega o le "Contact" mo le tuatusi imeli). ']
['O le DMCA e manaʻomia ai lau faʻasilasilaga o le faʻaleagaina o le puletaofia e aofia ai faʻamatalaga nei: (1) faʻamatalaga o le galuega faʻatagaina o loʻo faʻatatau i le faʻaleagaina o le puletaofia; (2) faʻamatalaga o le mea e ono solia ai ma faʻamatalaga lava e faʻatagaina ai matou ona maua le anotusi; (3) faʻamatalaga faʻafesoʻotaʻi mo oe, e aofia ai lau tuatusi, numera telefoni ma tuatusi imeli; (4) o se faʻamatalaga mai ia te oe o loʻo ia te oe le talitonuga lelei o le anotusi i le auala na faitio ai e le faʻatagaina e le pule o le puletaofia, poʻo lana sooupu, poʻo le faʻatinoina o soʻo se tulafono; ']
['(5) o se faamatalaga mai iā te oe, ua sainia i lalo o le faasalaga o le pepelo, e faapea o faamatalaga o loo i le faasilasilaga e saʻo ma e iai lau pule e faamalosia ai le aiā tatau lea o loo faapea mai ua solia; ']
['ma le (6) saini faaletino po o saini faaeletoroni a lē e ana le aiā tatau po o se tagata ua faatagaina e galue e fai ma sui o lē e ana le aiā tatau. ']
['Afai e lē o aofia uma faamatalaga o loo i luga, e ono faatuai ai ona iloilo lau faitioga.']
['Faafesootaʻi']
['Faamolemole lafo mai se imeli i so o se fesili / fautuaga.']
How to treat breast cancer?
The treatment for breast cancer depends on various factors such as the stage of cancer, the type of cancer, the patient's overall health, and personal preferences.
Some common treatment options include:
1. Surgery: This involves removing the tumor and surrounding tissue.
There are different types of surgery, including lumpectomy, mastectomy, and lymph node removal.
2. Radiation therapy: This uses high-energy radiation to kill cancer cells and shrink tumors.
It is often used after surgery to kill any remaining cancer cells.
3. Chemotherapy: This involves using drugs to kill cancer cells.
It can be given intravenously or or orally and is often used to shrink tumors before surgery or to kill any remaining cancer cells after surgery.
4. Hormone therapy: This is used for hormone-receptor-positive breast cancers and works by blocking the hormones that fuel the growth of cancer cells.
5. Targeted therapy: This uses drugs that target specific molecules involved in the growth and spread of cancer cells.
6. Immunotherapy: This helps the immune system recognize and attack cancer cells.
7. Clinical trials: Patients may also consider participating in clinical trials to access new and experimental treatments.
It is important to discuss the best treatment options with a healthcare team, as the treatment plan will be tailored to the individual's specific needs and circumstances.
Additionally, supportive care such as pain management, emotional support, and nutritional guidance may also be part of the treatment plan.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['E tusa o le']
['E faaaogā e le BioMedLib ni komepiuta (machine-learning algorithms) e faia ai ni fesili ma ni tali.']
['E amata i le 35 miliona lomiga faafomaʻi o le PubMed/Medline.']
['Tagaʻi i le "Faamatalaga" ma le "Faamatalaga".']
